Canada to require new assessment of AstraZeneca benefits, risks based on age
By David Ljunggren and Allison Martell Canada will modify its approval of AstraZeneca’s COVID-19 vaccine to require a new analysis of its benefits and risks based on age, the nation’s drug regulator said on Monday, as a separate federal advisory panel prepared to recommend the vaccine not be given to...